DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV3D-20; IGKV1-12; IGLC7; APOL1; JCHAIN; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA1; IGHA2; APOA1; APOE; IGLV7-43; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; SAA1; IGLC2; IGLC3; ADRB3; FOLR2; FOLR1; MRC1; IGHV1-2; FCGR2B; MASP1; HBA1; IGLV3-21; COLEC12; CLEC9A; AMN; STAB1; CD207;	GO:0006898~receptor-mediated endocytosis	64	160	40	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; C1R; CFB; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGLV7-43; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; C2; CFH; C1S; IGLC2; IGLC3; IGHV1-2; MASP1; IGLV3-21; COLEC10;	GO:0006956~complement activation	58	92	63.0434782608696	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; C1R; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGLV7-43; IGKV1D-39; IGKV3-11; CFI; IGKV2-30; IGKV4-1; IGKV5-2; C2; C1S; IGLC2; IGLC3; C4BPB; IGHV1-2; IGLV3-21; IGHV1-18; IGHV3OR16-13; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGLL5; CRP; IGHV3-15; IGHV1OR15-9; IGHV6-1; IGHV3-74; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHA1; IGHV1-58; IGHV3-73;	GO:0006958~complement activation, classical pathway	80	161	49.6894409937888	0	0	0	0	0	0	0
up	HTR3E; GRM6; KCNQ2; HCRTR2; GALR3; HTR3B; PMCH; DRD5; CBLN1; SLC6A2; GRIA1; SLC1A1; HTR3A; NPTX2; SLC1A6; HAP1; SST; FGF12; SLC18A2; GRIN2A; GRIK2; GRM1; GRM7; ASIC2; SYT10; HTR3C; PMCHL2; NRXN1; PCDHB10; PCDHB5; PCDHB11; HTR1E; GABRA4; GABRP; CACNB4; GABRE; HRH3; HTR4; GABRB2; CHRM1; CHRNA7; CHRM2; OR10H5; PENK; HTR1F; GABRA2; GABRG3; HRH1; GABRA5; HTR1D; GABRD;	GO:0007268~chemical synaptic transmission	51	249	20.4819277108434	0.00015581869192238	0.0206632898677071	0.738424781020171	0.743878435237454	0.714093692059714	0.738424781020171	0.186966823354835
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00019206934019877	0.0241299744765514	0.909832464521597	0.916939030108952	0.799392593907301	0.909832464521597	0.218334287734341
up	COL6A5; CHL1; ISLR; NCAN; EFS; DSCAM; NPHS1; CNTN5; ITGBL1; SPP1; HAPLN1; COL6A1; VCAM1; MAG; KITLG; CD9; AZGP1; ITGB8; EPHA8; COL15A1; CCL11; EMP2; SLURP1; MFAP4; CDH8; LGALS4; CLDN10; CX3CL1; TNFAIP6; MYBPC1; DPT; LGALS3BP; CNTN1; CDH17; MSLN; LSAMP; ITGA9; PKP1; LY6D; HABP2; DSC3; OPCML; POSTN; CDSN; FLG2; HES5; GRHL2; AMTN; EGFL6; SPACA4; MUC16; AMELX; CDHR5; STAB1; PCDHB8; PCDH17; PCDHA3; PCDH1; CDH16; PCDHA7; PCDHA10; PCDHAC2; PCDHA11; SIGLEC6; PCDH7; SIGLEC10; PCDHA5; PCDHB5; PCDHA9; PCDHB10; PCDHGB4; PCDHB11; SIGLEC8; PCDHA4; SIGLEC7; ICAM3; PCDHGC4; GPNMB; PCDHA8; PCDHA6;	GO:0007155~cell adhesion	80	454	17.6211453744493	0.00023825915202735	0.0291653638917586	1	1	0.872513849707552	0.999999999904809	0.263895801382135
up	SPINK4; CST8; PTTG1; CST1; SLPI; SPINK8; TFPI; PI3; SERPINB3; SPINK7; WFDC2; CST9; SPINT4; C3P1; ITIH5; WFDC5; WFDC12; CSTL1; WFDC1; FETUB; SERPINB13; SERPINA5; SERPINI2; TIMP4; SERPINB7; SERPINB4; HRG; SERPINA11; SERPINB2; KNG1; SERPINB12; SERPINB5; SERPINB11; SERPINA9;	GO:0010951~negative regulation of endopeptidase activity	34	148	22.972972972973	0.00031820169502683	0.0361840972699429	1	1	0.962796447750155	0.999999999904809	0.327403127277249
up	EDN1; TFPI; PCK1; LCN2; HYAL1; IL17A; PTGIS; ZC3H12A; SFRP1; CCL16; CCL25; CCL13; CCL14; XCL1; CCL26; CX3CL1; CCL11; CCL24; CCL18; CCL1; CCL23; CCL19;	GO:0071347~cellular response to interleukin-1	22	81	27.1604938271605	0.00054155966274316	0.0587592234076332	1	1	0.999999999904809	0.999999999904809	0.531668742666741
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8; PPARGC1A;	GO:0051552~flavone metabolic process	6	6	100	0.00056875871672934	0.0603389803036865	1	1	0.999999999904809	0.999999999904809	0.545962794118324
up	FOXE1; EYA4; FGF1; KRT18; HOXC13; CASR; KRT35; SIX2; PHLDA3; LYVE1; SOX17; FOXQ1; FOXD4L3; SOX21; SOX1; FOXD4L4; PITX2; FOXD4L5; SOX2; FOXS1; FOXA3; SRY; FOXD4; FBN3; PITX3; FOXA2; FOXA1; FOXI2; SOX18;	GO:0009653~anatomical structure morphogenesis	29	127	22.8346456692913	0.00091013422644681	0.0868996159411417	1	1	0.999999999904809	0.999999999904809	0.786290336499709
down	TRAV27; NCR3; AIRE; FCGR3B; IL18RAP; S1PR4; IL2RA; TRBV12-3; TRAV8-4; IGHV3-13; TRBC1; IGHD; HLA-H; MBP; FTH1; TRGV3; TRGC2; TRBV7-9; TRAV29DV5; CSF3; CD8B; GZMA; OSM; RAG1; CTLA4; ENDOU; TNFSF4; FCAR; HRH2; CNR2; CD79B; OPRK1; KIR2DL1; KIR2DL3; KIR3DL1; SERPINB9; IL2; HAMP; SP2; IRF8; RGS1; IL10RB; GPR65; LILRB2; PXDN; SEMA4D; SEMA3C; IL21; CYSLTR2; IL36A; APLN; ICOS; CD80; TLR7; TRAV18; TRAV38-1; CXCR5; CCR10; CCR5; TLR8; CXCR3; TRAV2; CCR7; TRDV3; TRDV1; TLR9; FCGRT; TRDV2; PF4; PPBP; CCR6; TRAV14DV4; TRAV9-2; CXCR2; TRAV40; XCR1; CXCL3; IGKV1-8; CXCL2; TRAV38-2DV8; TRAV19; CCR2;	GO:0006955~immune response	82	433	18.9376443418014	0.00104447461426382	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	MSGN1; SRRM4; SPATA31C2; KRT6A; TFF1; INHA; FGF1; SPATA31C1; TDGF1; PMCH; MDK; HIST1H1T; ANXA13; COL15A1; ADCYAP1R1; TPPP2; KRTDAP; BNC1; MECOM; ANGPT1; ECSCR; ODF4; ZNF750; TMEM176B; MORN2; ZC3H12A; NKAPL; COL13A1; CXCL17; SPATA31E1; SPATA19; MROH2B; SLC22A16; EGFL6; ANKS4B; VSTM2A; ACER1; TCP11; NELL1; TESC; KAZALD1; ATOH8; RARRES2; CDHR5; NPAP1; THEG; SPIC; SOX17; NKX2-8; HES5; FOXA2; POU2F3; FOXA1; FOXD4L3; SPINK6; FOXS1; NR1H4; EYA4; SOX1; FOXI2; ID1; HNF4A; FOXA3; SPDEF; NKX6-1; CDX1; FOXD4; RARB; RXRG; ONECUT3; CCDC160; SOX18; NKX3-2; NKX6-2; FOXQ1; FOXD4L5; HNF4G; ID3; SRY; NKX2-3; SOX2; ETV7; EHF; DLX5; HES2; NKX1-2; SOX21; HES4; ID4; FOXD4L4; DLX3; FOXE1;	GO:0030154~cell differentiation	92	572	16.0839160839161	0.00119502408902161	0.111863627470376	1	1	0.999999999904809	0.999999999904809	1
up	CHL1; TOX3; NTRK1; MAG; MDK; ERBB3; PTPRZ1; CNTFR; GABRA5; GDNF; GDF5; GABRB2; NES; ISL1; GRIK2; ANGPT1; NTRK2; BHLHB9; SLC30A10; TFAP2B; VSTM2L; FAIM2; BARHL1; FOXQ1; FGF20; PPARGC1A; APOE; NTF4; BDNF; NTF3;	GO:0043524~negative regulation of neuron apoptotic process	30	138	21.7391304347826	0.00146180939486507	0.131764582223497	1	1	0.999999999904809	0.999999999904809	1
up	CCL24; HRH1; CCL11; CCL13; CCL1; CX3CL1; CCL18; CCL23; XCL1;	GO:0048245~eosinophil chemotaxis	9	20	45	0.00165214821893123	0.14340646540323	1	1	0.999999999904809	0.999999999904809	1
up	CA2; KRT6A; KRT16; SERPINB5; RIPK4; TBX4; CA9; TBX5;	GO:0002009~morphogenesis of an epithelium	8	17	47.0588235294118	0.00239583830619794	0.196101679575857	1	1	0.999999999904809	0.999999999904809	1
up	AQP7; AQP1; MIP; AQP2; AQP5; AQP4; PDZD3; AQP3;	GO:0006833~water transport	8	17	47.0588235294118	0.00239583830619794	0.196101679575857	1	1	0.999999999904809	0.999999999904809	1
up	APOE; EDN3; DRD5; CCL1; KEL; CDH5; CHRNA7; CASR; CSRP3; CCL11; STC1; CCL23; GRIK2; TRDN; RGN; CCL14; TRPM8; CCL13; CCL19; ATP13A4; ATP13A5; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	22	94	23.4042553191489	0.0027471797354327	0.216205102230036	1	1	0.999999999904809	0.999999999904809	1
up	FGF10; MET; GLI2; BMP4; BMP7; HNF1B; CASR; SHH; RASIP1;	GO:0048754~branching morphogenesis of an epithelial tube	9	22	40.9090909090909	0.00276257043067285	0.216205102230036	1	1	0.999999999904809	0.999999999904809	1
down	SLIT2; PFN1; PFN2; PRKCD; FHOD3; TWF2; MYADM; FAM49B; KANK4;	GO:0030837~negative regulation of actin filament polymerization	9	19	47.3684210526316	0.00284130459368481	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	TCF21; LIF; ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	5	6	83.3333333333333	0.00286597742867034	0.220680262007616	1	1	0.999999999904809	0.999999999904809	1
up	FGF10; TCF21; HNF1B; FOXF1; IHH; SHH; OVOL2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	8	18	44.4444444444444	0.00315775897545956	0.235549083575686	1	1	0.999999999904809	0.999999999904809	1
up	AGRP; GPR37; HCRTR2; ECEL1; POMC; NMB; CPE; ADCYAP1; PMCH; NTS; NMU; NPY4R; GPR143; NPSR1; SORCS1; QRFPR; NPVF; SSTR1; GALR2; GALR3; PYY; SSTR5; PENK; UTS2R;	GO:0007218~neuropeptide signaling pathway	24	108	22.2222222222222	0.00323597982273871	0.237670271903917	1	1	0.999999999904809	0.999999999904809	1
up	CLCA1; CASQ2; GRID2; ATP8B1; ATP2C2; S100A6; ATP4A; CHRNA7; SCNN1A; GRIA1; SCNN1G; CLCNKB; ATP12A; GRIK2; GRIK3; TRDN; FXYD3; ASIC2; ANO4; ATP13A5; ATP13A4; ANO1; TMC5; ANO3; ATP6V0A4; SGK2; ASIC5; GABRA5; GABRG3; GABRP; GABRA2; HTR3C; GABRD; GABRE; GABRA4; HTR3B; HTR3A; HTR3E; GABRB2;	GO:0034220~ion transmembrane transport	39	208	18.75	0.00338577947938212	0.244904715675307	1	1	0.999999999904809	0.999999999904809	1
up	SRRM4; MSI1; KCNQ2; DSCAM; LGI1; GJB1; CHRM2; CXCL1; CHRM1; PCSK2; NTF3; MDK; CBLN1; BDNF; EDNRB; CNTFR; GDNF; DLX5; FGF12; PCDH1; LSAMP; ZC3H12A; CNTN4; PLPPR1; ST8SIA2; RAPGEF5; NELL1; FGF14; ATOH8; DPYSL5; SDCBP2; NRN1; PCDHA7; PCDHA6; PCDHA4; GDA; PCDHB11; PCDHA8; PCDHA5; PCDHA3; PCDHA11; PCDHA10; PCDHAC2; ERBB3; GFRA3; NTRK1; BARHL1; NTRK2; RBFOX1; PHOX2A; GFRA4;	GO:0007399~nervous system development	51	294	17.3469387755102	0.00375583318533079	0.259183109136623	1	1	0.999999999904809	0.999999999904809	1
up	CLCA1; GABRP; CLDN4; GABRD; APOL1; SLC26A4; CASR; SLC1A1; GABRA2; GABRB2; CLCNKB; CLDN17; FXYD3; ANO4; ANO1; SLC26A9; CLIC6; ANO3; GABRA4; GABRG3; GABRA5; GABRE;	GO:1902476~chloride transmembrane transport	22	97	22.680412371134	0.0038003388436455	0.259183109136623	1	1	0.999999999904809	0.999999999904809	1
up	LTF; APOA4; NOS2; H2BFS; DEFB1; BPIFB1; DEFA5; DEFA6;	GO:0002227~innate immune response in mucosa	8	19	42.1052631578947	0.00409522253308603	0.271536005179899	1	1	0.999999999904809	0.999999999904809	1
down	F8; F2; PF4; RAF1; GP1BA; DGKA; PRKCH; PIK3R1; CD40LG; GP5; SYK; P2RX1; RAP2B; PRKCE; GNA12; PRKCD; TRPC3; ITPR2; DGKK; PDPN; TREML1; PIK3R5; GP6; CLEC1B; AXL;	GO:0030168~platelet activation	25	102	24.5098039215686	0.00420655155206962	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	CLDN1; ASS1; EDN1; TDGF1; PCK1; LCN2; HYAL1; POSTN; OCLN; ZC3H12A; NPNT; SFRP1; PPARGC1A; CCL25; CCL1; CCL23; CX3CL1; CCL26; CCL24; CCL14; CCL19; CCL13; CCL18; CCL16; CCL11; XCL1;	GO:0071356~cellular response to tumor necrosis factor	26	125	20.8	0.00480551805434626	0.305887242552654	1	1	0.999999999904809	0.999999999904809	1
up	KRT14; PKP1; PKP2; EPPK1;	GO:0045110~intermediate filament bundle assembly	4	4	100	0.00519681812977035	0.31624088575551	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; EDN3; HRC; AVPR1A; SLC1A1; NMU; RGS4; TRPM4;	GO:0010460~positive regulation of heart rate	8	20	40	0.00523314410864795	0.31624088575551	1	1	0.999999999904809	0.999999999904809	1
up	CLDN7; NTN1; EPCAM; C1QTNF8; DUOXA2; CCL19; DUOX2; DUOX1;	GO:2000147~positive regulation of cell motility	8	20	40	0.00523314410864795	0.31624088575551	1	1	0.999999999904809	0.999999999904809	1
up	UGT1A9; UGT2B11; AKR7A3; CYP2E1; SULT1A3; CYP2C9; DPEP1; UGT1A6; AOC1; AADAC; CYP2F1; FMO3; CYP2C18; CYP2C19; HNF4A; UGT2B15; CES3; ACY3; GSTA1; CYP2S1; GSTA3;	GO:0006805~xenobiotic metabolic process	21	94	22.3404255319149	0.00534407449128815	0.318907645267621	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; EDN3; KEL; EDNRB; EDNRA; HTR1D; TRPM4;	GO:0042310~vasoconstriction	7	16	43.75	0.00606984723589021	0.35639491615837	1	1	0.999999999904809	0.999999999904809	1
up	CLDN1; ASS1; EDN1; TDGF1; MRC1; IL12B; NOS2; AQP4; CCL23; CCL1; XCL1; CCL13; CCL16; CX3CL1; CCL24; CCL14; CCL19; CCL11; CCL18; CCL25; CCL26;	GO:0071346~cellular response to interferon-gamma	21	96	21.875	0.00654184514396139	0.356449970510625	1	1	0.999999999904809	0.999999999904809	1
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2E1; CYP2S1; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	8	21	38.0952380952381	0.00659733301897047	0.356449970510625	1	1	0.999999999904809	0.999999999904809	1
up	GPR37; FGF10; ALOX12B; IGF1; ADRA2A; KIT; BMP2; ADRB3; LIF; IGFBP3; ADRA2C; EFNA1; FGFR3; IGFBP4; EPHA8; ADRA1A; FLT4; THPO; SOX2; CX3CL1; NTRK2; C1QTNF1; NTRK1;	GO:0043410~positive regulation of MAPK cascade	23	109	21.1009174311927	0.00662857734622146	0.356449970510625	1	1	0.999999999904809	0.999999999904809	1
up	C1QL1; C1QA; EPHA8; CX3CL1; RND1; NTN4;	GO:0016322~neuron remodeling	6	12	50	0.00670961750210863	0.356449970510625	1	1	0.999999999904809	0.999999999904809	1
up	APOA1; APOE; APOC1; APOC3; APOA4; ABCA12;	GO:0033700~phospholipid efflux	6	12	50	0.00670961750210863	0.356449970510625	1	1	0.999999999904809	0.999999999904809	1
up	SULT1C2; INMT; CYP1A1; VCAM1; AOC1;	GO:0009308~amine metabolic process	5	8	62.5	0.00671983605906079	0.356449970510625	1	1	0.999999999904809	0.999999999904809	1
up	IGFBP2; IGFBP4; IGFBP3; IGFBP6; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	5	8	62.5	0.00671983605906079	0.356449970510625	1	1	0.999999999904809	0.999999999904809	1
up	CXCL11; GALR2; RAMP3; VIP; CXCL10; ADRA2A; ADCYAP1; DRD1; DRD5; CALCR; GCGR; CXCL9; ADCY2; ADGRF1; GPR26; ADGRG6; LGR4; PTGFR; PTGER1; FSHR; ADGRL4; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	22	103	21.3592233009709	0.00692691621996566	0.363396681693583	1	1	0.999999999904809	0.999999999904809	1
up	GFRA3; ERBB3; EDNRB; ASIC2; UGT8; BDNF; NTF3; NTF4; GDNF;	GO:0007422~peripheral nervous system development	9	27	33.3333333333333	0.00813232036261202	0.413018057564998	1	1	0.999999999904809	0.999999999904809	1
up	NTN1; THY1; KRT18; CRISP2; COL8A2; S100A11; ICAM3; CDH5; ITGA8; CX3CL1; CDC42EP1; FOXF1; TRIM29; CDSN; COL13A1; PKP2; CRNN; ZAN; LRRC1; DSG4; CDH17; CDH12; DSC3; CDH26; CDH19; IGSF5; CDH8; PKP1; CDHR2;	GO:0098609~cell-cell adhesion	29	152	19.0789473684211	0.00849142669382352	0.423782351520371	1	1	0.999999999904809	0.999999999904809	1
up	APOE; EDN1; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	4	5	80	0.00861057563834855	0.423782351520371	1	1	0.999999999904809	0.999999999904809	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00861057563834855	0.423782351520371	1	1	0.999999999904809	0.999999999904809	1
up	JCHAIN; IGKV3-20; IGHA1; IGHA2; SULF1; ADGRF5;	GO:0003094~glomerular filtration	6	13	46.1538461538462	0.00898047943958935	0.428728088445996	1	1	0.999999999904809	0.999999999904809	1
up	GABRB2; GABRG3; GABRA5; GABRA4; GABRA2; GABRE;	GO:0051932~synaptic transmission, GABAergic	6	13	46.1538461538462	0.00898047943958935	0.428728088445996	1	1	0.999999999904809	0.999999999904809	1
up	BMP4; ERBB3; GATA4; FOXF1; TBX5;	GO:0003197~endocardial cushion development	5	9	55.5555555555556	0.00959387545645662	0.440395782972345	1	1	0.999999999904809	0.999999999904809	1
up	APOA1; APOE; APOC3; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.00959387545645662	0.440395782972345	1	1	0.999999999904809	0.999999999904809	1
up	ADRA2A; ADRB3; DRD5; DRD1; DRD2; ADRA1A; PMCHL2; ADRA2C; PMCH;	GO:0007610~behavior	9	28	32.1428571428571	0.0098031449680912	0.445716324549213	1	1	0.999999999904809	0.999999999904809	1
up	DES; KRT9; KRT20; EPPK1; KRT17; SHH; TCHH;	GO:0045109~intermediate filament organization	7	18	38.8888888888889	0.00994870332550502	0.448067072414726	1	1	0.999999999904809	0.999999999904809	1
down	MT1X; MT1E; MT2A; MT1H; MT1F; MT1L; MT1G;	GO:0010273~detoxification of copper ion	7	16	43.75	0.0114032268418833	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	CNTFR; HNF4A; SRY; AMHR2; DMRTC2; DMRT3;	GO:0007548~sex differentiation	6	14	42.8571428571429	0.0117514500266341	0.506728213005096	1	1	0.999999999904809	0.999999999904809	1
up	CLDN5; BIRC5; PRC1; CHP2; CLDN7; NTN1; GLP2R; VIP; KRT6A; CXCL10; S100B; IGF1; SLC25A5; FGF1; EDN1; CCK; ADRA2A; NMB; KIT; BMP4; TDGF1; EDN3; FOLR2; LIF; EPCAM; ADCYAP1; NTF3; KITLG; FGF7; BMP5; FGFR3; EDNRB; CNTFR; SERPINB3; CCKBR; TTK; FLT4; CHRNA7; AVPR1A; GDNF; CEACAM6; MYCNOS; THPO; CASR; AKR1C3; MATK; PTGFR; ID4; EMP2; ISL1; CX3CL1; BNC1; MST1R; CDC20; BAMBI; KLF5; SHH; NTRK2; CCL14; HES5; GCNT2; DYNAP; SFRP1; TRPM4; TFAP2B; TSLP; OSMR; GAREM1; FGF20; FGF21; REG1A; ERBB3; REG3A; PROK1;	GO:0008284~positive regulation of cell population proliferation	74	490	15.1020408163265	0.0120882115342182	0.506728213005096	1	1	0.999999999904809	0.999999999904809	1
up	PLA2G10; NMB; DRD2; PLA2G4F; PLA2G2F; PLA2G3; PLA2G2D; PLA2G5;	GO:0050482~arachidonic acid secretion	8	24	33.3333333333333	0.0123126252007941	0.506728213005096	1	1	0.999999999904809	0.999999999904809	1
up	CLDN4; CLDN3; CLDN1; ADRA2A; REG3A; OCLN; DUOX2; DUOX1;	GO:0090303~positive regulation of wound healing	8	24	33.3333333333333	0.0123126252007941	0.506728213005096	1	1	0.999999999904809	0.999999999904809	1
up	APOL1; APOC1; APOC3; APOL4; APOL5; APOA4; APOA1;	GO:0042157~lipoprotein metabolic process	7	19	36.8421052631579	0.0124506301913236	0.508028278063069	1	1	0.999999999904809	0.999999999904809	1
up	DRD2; DRD1; GDNF; P2RX3; TIFAB;	GO:0030432~peristalsis	5	10	50	0.0132115777175481	0.52137387491863	1	1	0.999999999904809	0.999999999904809	1
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.0132115777175481	0.52137387491863	1	1	0.999999999904809	0.999999999904809	1
up	NTRK1; BDNF; NTF4; NTRK2;	GO:0042490~mechanoreceptor differentiation	4	6	66.6666666666667	0.0132145452168316	0.52137387491863	1	1	0.999999999904809	0.999999999904809	1
up	GJB6; GJB2; MIP; GJB4;	GO:1990349~gap junction-mediated intercellular transport	4	6	66.6666666666667	0.0132145452168316	0.52137387491863	1	1	0.999999999904809	0.999999999904809	1
up	TNFRSF11B; NCAN; MATN4; DCN; SPP1; HAPLN1; COL6A1; ELN; VCAM1; FBLN1; COL8A2; ITGB8; LOX; ICAM3; SERPINB5; LUM; ITGA8; FOXF1; FOXF2; MFAP5; ITGA9; COL13A1; EGFLAM; VWA1; NPNT; ADAMTSL2; EGFL6; KAZALD1; ADAMTS9; MMP27; COL23A1; COL15A1; MMP23B; MMP12; MMP7; MMP1; MMP28; MMP3; POSTN;	GO:0030198~extracellular matrix organization	39	230	16.9565217391304	0.0137283764739187	0.53720712529908	1	1	0.999999999904809	0.999999999904809	1
down	IFNG; TNFSF4; CD40LG; CCR7; IRF8; IRF5; IL23R; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	9	26	34.6153846153846	0.0140076887066396	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	MUC2; MUC4; MUC13; TFF3; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	6	15	40	0.0150733423358583	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
down	WNT7A; FZD7; ZFP36L2; TGFB2; VANGL2;	GO:0048103~somatic stem cell division	5	9	55.5555555555556	0.0155635086905728	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	IGHD; ORM1; ORM2; PANX3; PANX2;	GO:0050716~positive regulation of interleukin-1 secretion	5	9	55.5555555555556	0.0155635086905728	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	MAP1LC3A; GABARAP; NPRL2; MAP1LC3B; GABARAPL2; MAP1LC3B2;	GO:0006995~cellular response to nitrogen starvation	6	13	46.1538461538462	0.0156001025439251	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	GLI2; HOXB1; HOXD10; HOXD3; HOXC8; HOXC13; HNF1B; EMX2; BARX1; HOXC5; HES4; TDGF1; HOXA6; HOXB6; HOXD9; HOXA7; HOXC9; HOXD4; HES2; HES5;	GO:0009952~anterior/posterior pattern specification	20	99	20.2020202020202	0.0158022680196502	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	SLC1A7; SLC13A2; SLC25A10;	GO:0006835~dicarboxylic acid transport	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	HPCA; RD3; PDZD3;	GO:0031283~negative regulation of guanylate cyclase activity	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	FOXH1; BMP2; GATA4;	GO:0035054~embryonic heart tube anterior/posterior pattern specification	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	ISL1; MESP1; SOX17;	GO:0060913~cardiac cell fate determination	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	UNC5C; NTN1; SEMA3B;	GO:0061643~chemorepulsion of axon	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	TRPM2; P2RY1; P2RY6;	GO:0071415~cellular response to purine-containing compound	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	HAS3; BMP7; HYAL1;	GO:1900106~positive regulation of hyaluranon cable assembly	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	ZC3H12A; NR1H4; IL36RN;	GO:1902714~negative regulation of interferon-gamma secretion	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	PCK1; FGF21; PPARGC1A;	GO:1904640~response to methionine	3	3	100	0.0162615786915142	0.575057604987325	1	1	0.999999999904809	0.999999999904809	1
up	CLDN3; CLDN7; CLDN1; PENK; S100A8; CYP2E1; CDK1; ADCYAP1; MAOB; ADH6; IL13; APOBEC1; ADCYAP1R1; HTR3A; RGS4; CLDN18; ACTC1; GRIN2A; GGH; KCNC2;	GO:0045471~response to ethanol	20	100	20	0.0172142434446974	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	PLA2G10; PLA2G5; PLA2G4E; PLA1A; PLA2G4F; PLA2G2F; PLA2G2D;	GO:0036150~phosphatidylserine acyl-chain remodeling	7	21	33.3333333333333	0.018755649126065	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	PHOX2A; PITX3; FOXA1; SHH; SFRP1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	7	21	33.3333333333333	0.018755649126065	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	ADRA2A; ADRA1A; DRD1; ADRA2C; DRD5; DRD2; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	7	21	33.3333333333333	0.018755649126065	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	GRM6; GRIK3; GRM1; TRPM1; GRM7; GRM8;	GO:0007216~G protein-coupled glutamate receptor signaling pathway	6	16	37.5	0.0189934593874365	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	ALOX12B; ALOX15; PON1; LTC4S; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	6	16	37.5	0.0189934593874365	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	PTGES; CXCL13; S100A8; CCL11;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	GRM8; GRM6; GRIK3; GRM7;	GO:0007196~adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	CYP19A1; MIF; MMP28; SLAMF8;	GO:0010760~negative regulation of macrophage chemotaxis	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	AQP7; AQP1; AQP2; AQP3;	GO:0015793~glycerol transport	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	SLC22A3; POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	PLS1; CDHR2; CDHR5; USH1C;	GO:0032532~regulation of microvillus length	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	BMP2; BMP4; APCDD1; DMRT3;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; NMB; EDN3; P2RY1;	GO:0046887~positive regulation of hormone secretion	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	LIF; FOXF1; SHH; GRHL2;	GO:0060463~lung lobe morphogenesis	4	7	57.1428571428571	0.0191280125243609	0.592968388255188	1	1	0.999999999904809	0.999999999904809	1
up	ODAM; APOL1; SLC34A2; TSPAN15; KNG1; PENK; APOA1; APOE; LTF; MMP1; IGF1; APOA4; KLK3; CTSG; PGA3; PGA5; SAA1; SPP1; BMP4; IGFBP3; IGFBP2; IGFBP4; HRC; IGFBP6; IGFBP5; MSLN; NOTUM; VWA1; AMTN; HIST2H3A; SFTPA2; AMELX; DMBT1; SNCAIP;	GO:0044267~cellular protein metabolic process	34	200	17	0.0196398329995658	0.604906856386628	1	1	0.999999999904809	0.999999999904809	1
down	PF4; SPI1; IL10; TAF7;	GO:0045347~negative regulation of MHC class II biosynthetic process	4	6	66.6666666666667	0.019773815718356	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	YWHAB; DBN1; GET4; DZIP1;	GO:0051220~cytoplasmic sequestering of protein	4	6	66.6666666666667	0.019773815718356	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	IFNG; CCL2; CCR2; PINK1;	GO:1904783~positive regulation of NMDA glutamate receptor activity	4	6	66.6666666666667	0.019773815718356	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	FN1; LAMB1; INHBA; MMP8; HMGA2; COL7A1; LAMB3; LAMA3; MIXL1;	GO:0035987~endodermal cell differentiation	9	28	32.1428571428571	0.0200725496776019	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	SPI1; GLRA1; CCL7; PRKCE; ITPR2; DNMT3A;	GO:0071361~cellular response to ethanol	6	14	42.8571428571429	0.020190867695722	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	ACOD1; LDOC1; SERPINE1; VIM; CSF3; CCL2; IL10; TNFSF4; ZFP36; AXL; MAPK8; CCR5; RHOA; HAMP; IRF8; IL24; LILRB2; LILRB1; NLRP7; MYD88; HDAC5; DEFA4; PF4; CXCL2; CD80; NR1H2; NR1I2; CXCL3; DEFA3; CD180; PPBP; IL36A;	GO:0071222~cellular response to lipopolysaccharide	32	163	19.6319018404908	0.0208444935999946	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	SHISA7; BDNF; GABRA2; GABRB2; GABRA4; GABRG3; GABRA5; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	8	27	29.6296296296296	0.0210142628272071	0.643090325237735	1	1	0.999999999904809	0.999999999904809	1
down	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.0223987625378104	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	MTRNR2L5; ACAA2; BNIP3;	GO:1902109~negative regulation of mitochondrial membrane permeability involved in apoptotic process	3	3	100	0.0223987625378104	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	OAZ2; OAZ1; OAZ3;	GO:1902268~negative regulation of polyamine transmembrane transport	3	3	100	0.0223987625378104	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0223987625378104	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	CIDEA; TRPM2; DRD2; DRD1; NMU; PPARGC1A; ADRB3;	GO:0001659~temperature homeostasis	7	22	31.8181818181818	0.0226242042510064	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	SLC26A4; EDN1; EDNRB; ATP12A; ATP6V0A4;	GO:0006885~regulation of pH	5	12	41.6666666666667	0.0229643907841275	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CPA1; ALOX15; DPEP1; GGT5; CYP4A11; LTC4S;	GO:0006691~leukotriene metabolic process	6	17	35.2941176470588	0.023554734264431	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	C1R; PRSS3; KLK2; KLK3; CD5L; KLK1;	GO:0031638~zymogen activation	6	17	35.2941176470588	0.023554734264431	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	F2; PRL; AKR1B1; IL10; IL10RB; IFNL1; CRLF3; IL26; GHR;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	9	29	31.0344827586207	0.0237271794825475	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	KCNU1; KCNK1; KCNQ2; KCNK2; AQP1; ABCC8; KCNJ8; LRRC26; LRRC55; KCNG4; KCNB2; KCNC2; P2RY12; KCNN2; KCNK4; KCNIP1; HCN4; KCNS3; SLC9A4; KCNK5; SLC9A3; SLC9A2; KCNH5;	GO:0071805~potassium ion transmembrane transport	23	125	18.4	0.0243865885852567	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	HRG; S100A8; S100A9; CTSG; DEFA5; DEFA6; IL17A; NLRP10;	GO:0050832~defense response to fungus	8	28	28.5714285714286	0.0246948178171286	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	WDR1; EPB41L3; RAC2; PPP2R3C; RTKN; RHOG;	GO:0030865~cortical cytoskeleton organization	6	15	40	0.0256177949761882	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	TCF21; PGR; BMP4; LIF; IGFBP5; FLT4; FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	9	34	26.4705882352941	0.0256909412691892	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	RBP1; ALDH1A3; RDH10;	GO:0002138~retinoic acid biosynthetic process	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CYP2E1; EDN1; SCGB1A1;	GO:0010193~response to ozone	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; EDN3; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	SLC26A4; ANO1; SLC5A5;	GO:0015705~iodide transport	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CA2; AVPR1A; CA7;	GO:0032849~positive regulation of cellular pH reduction	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	MESP1; GATA5; ROBO2;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	BMP4; BMP7; SULF1;	GO:0060686~negative regulation of prostatic bud formation	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	MCIDAS; CCNO; DEUP1;	GO:1903251~multi-ciliated epithelial cell differentiation	3	4	75	0.0263399224991852	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	ADRA2A; ADRA2C; P2RY1; P2RY12;	GO:0010700~negative regulation of norepinephrine secretion	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	APOA4; AADAC; FGF21; APOA1;	GO:0010898~positive regulation of triglyceride catabolic process	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	GJB6; GJB1; GJB2; GJA5;	GO:0016264~gap junction assembly	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	HOXD9; HOXD10; GDF5; TFAP2B;	GO:0035137~hindlimb morphogenesis	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	RP1; NTRK2; TRPM1; RORB;	GO:0046548~retinal rod cell development	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CYP1A1; MAOB; DUOX2; DUOX1;	GO:0050665~hydrogen peroxide biosynthetic process	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	AQP1; SCNN1A; SCNN1G; AQP4;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	4	8	50	0.0264385948179404	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	RTL1; WNT9B; GALR2; PI15; NOBOX; SPDEF; EYA4; FGF1; HOXD4; EDN3; HOXB1; LIF; PMCH; FLG; HIST1H1T; CRABP1; MYCNOS; THPO; MEOX2; FOXA3; HUNK; TBX4; ID3; HLF; ODF4; CEP55; ANO1; TXNDC8; CATSPER4; SPATA19; SLC22A16; PLCZ1; EGFL6; PRR15; GCNT2; TCP11; CREB3L1; KAZALD1; PIWIL1; PRRX2; TSSK1B; AMN; EBF3; SCUBE2; OLFML3; FMN2; EHF; NPAP1; ADAMTS9; THEG; DKK4; NKX1-2; DMBT1; WIF1; NR1H4; EPHA8; EPHA5; CDH12; RARB; CDH5; NTRK1; FLT4; FGFR3; CDH19; CDH8; ERBB3; MST1R; NTRK2; SPINK6; CDH17; CDH26; MET; EPHB3; KIT;	GO:0007275~multicellular organism development	74	513	14.4249512670565	0.0277641200445212	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	INHBA; ITGB4; ITGA2; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.0280219167042013	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	MT2A; MT1E; MT1F; MT1G; GLRA1; MT1H; MT1X; MT1L;	GO:0071294~cellular response to zinc ion	8	25	32	0.0281720352096222	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	OAZ2; OAZ1; SMOX; OAZ3;	GO:0006596~polyamine biosynthetic process	4	7	57.1428571428571	0.0283280186252697	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	LPXN; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0283280186252697	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	PTGES; HPGDS; GSTA1; AKR1C3; CYP4F8; CYP2S1;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.0287950119792337	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	GLI2; BMP7; BMP5; HNF1B; SHH; SMAD1;	GO:0030902~hindbrain development	6	18	33.3333333333333	0.0287950119792337	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	PLA2G10; PLA2G5; PLA2G4F; PLA2G2F; PLA2G3; PLA2G2D;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	6	18	33.3333333333333	0.0287950119792337	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	IL12B; XCL1; CD1B; CD1C; AZGP1; CD1E; HLA-G; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	8	29	27.5862068965517	0.0288028654995026	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	KNG1; APOE; EDN1; TFPI; TSPAN8;	GO:0030195~negative regulation of blood coagulation	5	13	38.4615384615385	0.0292162266618397	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	DRD2; NPR1; DRD1; GRIN2A; SNCAIP;	GO:0042417~dopamine metabolic process	5	13	38.4615384615385	0.0292162266618397	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	FGF10; KIT; COL8A2; HNF1B; EHF;	GO:0050673~epithelial cell proliferation	5	13	38.4615384615385	0.0292162266618397	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	DEFB4A; LTF; DEFA5; DEFA6; LCE3A; MUC7; PGLYRP4; PGLYRP3; CCL13;	GO:0031640~killing of cells of other organism	9	35	25.7142857142857	0.0294946225857269	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	GRXCR2; SRRM4; BIRC5; SLC26A4; ATP8B1; CNTN5; GJB6; EYA4; GJB2; GABRA5; GABRB2; CLRN1; GRM7; ASIC2; CEACAM16; OTOG; MYH14; MARVELD2; MYO3A; BARHL1; ATP6V0A4; SLC52A3; MYO1A; DCDC2; USH1C;	GO:0007605~sensory perception of sound	25	143	17.4825174825175	0.0315887852267585	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	TYROBP; CTLA4; IL10; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0319329307310846	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	EFNA1; BMP5; FOXA1; SFRP1; TBX5; OVOL2; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	7	24	29.1666666666667	0.0319388657682623	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CX3CL1; CXCL10; CXCL11; CXCL13; CXCL6; CXCL9; CXCL1;	GO:0030595~leukocyte chemotaxis	7	24	29.1666666666667	0.0319388657682623	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CCL24; CXCL11; DEFB4A; CCL25; CCL16; CXCL14; CXCL10; HRG; CXCL1; CCL1; CCL11; CCL23; CCL18; DEFB1; CX3CL1; CXCL6; CXCL9; ECSCR; CMTM5; CCL13; RARRES2; CCL26;	GO:0006935~chemotaxis	22	122	18.0327868852459	0.032279872067412	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	SOCS2; PIAS1; IFNG; GHR; CCL2; CCR2; IFNAR2; IFNL1; IL31RA;	GO:0007259~receptor signaling pathway via JAK-STAT	9	31	29.0322580645161	0.0324095794882343	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	BIRC5; SOCS1; F13A1; POMC; IGHG4; CXCL10; MMP1; IL5; MMP3; CXCL1; SAA1; KIT; LIF; MUC1; ALOX15; VCAM1; PTPRZ1; CNTFR; IL12B; IL13; NOS2; SOX2; CCL11; CX3CL1; LCN2; IL13RA2; IL17A; IL20RB; IL17REL; IFNL3; IL17RD; IL1F10; IL22RA2; OSMR; CCL19; DUOX2; DUOX1; IL36B; IL36G; IL36RN; IL19; IL20RA; IL37;	GO:0019221~cytokine-mediated signaling pathway	43	278	15.4676258992806	0.0342179515507957	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	PLA2G10; PLA2G5; PLA2G4E; PLA2G4F; PLA2G2F; PLA2G2D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	6	19	31.5789473684211	0.0347464778698925	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	IDO1; HAAO; TDO2; IDO2;	GO:0006569~tryptophan catabolic process	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	HTR3E; HTR3B; HTR3A; HTR3C;	GO:0007210~serotonin receptor signaling pathway	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	SLC22A2; VIP; EDN1; NPR1;	GO:0007589~body fluid secretion	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; EDNRA; OCLN; FFAR4;	GO:0010827~regulation of glucose transmembrane transport	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	APOA1; APOE; APOC1; APOA4;	GO:0010873~positive regulation of cholesterol esterification	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	FCGR2B; ZC3H12A; ADGRF5; LRFN5;	GO:0043031~negative regulation of macrophage activation	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	APOA1; SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	GATA4; FOXF1; SHH; SOX17;	GO:0048617~embryonic foregut morphogenesis	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	ODAM; FGF10; CLDN1; MMP12;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	4	9	44.4444444444444	0.0352024875996683	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	SLC6A1; P2RX7; TRH;	GO:0014054~positive regulation of gamma-aminobutyric acid secretion	3	4	75	0.035926834280946	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.035926834280946	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	CCR6; SPNS2; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.035926834280946	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	ITGB4; LAMB3; LAMC2; LAMA3; COL17A1;	GO:0031581~hemidesmosome assembly	5	12	41.6666666666667	0.0360823401065316	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	PTGES; FGF10; GJB6; CLDN1; PENK; SLPI; CYP1A1; S100A8; EDN1; DCN; SCGB1A1; IDO1; SELE; UGT1A1; MAOB; GJB2; S100A7; PTGER1; IL13; PCK1; PTGFR; TIMP4; GGT5; NOS2;	GO:0032496~response to lipopolysaccharide	24	138	17.3913043478261	0.0362274136081011	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	P2RY1; P2RY6; P2RY13; GPR87; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	5	14	35.7142857142857	0.0364432792412256	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; DRD2; NPR1; EDNRB; TFAP2B;	GO:0035810~positive regulation of urine volume	5	14	35.7142857142857	0.0364432792412256	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; DRD2; NPR1; EDNRB; AVPR1A;	GO:0035815~positive regulation of renal sodium excretion	5	14	35.7142857142857	0.0364432792412256	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	AKR1C3; ALDH1A3; RDH10; SDR16C5; BCO1;	GO:0042574~retinal metabolic process	5	14	35.7142857142857	0.0364432792412256	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	BMP4; ITGA8; IHH; SHH; STRA6;	GO:0048745~smooth muscle tissue development	5	14	35.7142857142857	0.0364432792412256	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	RAMP3; MMP3; CALCR; CHRNA7; MMP12;	GO:1904645~response to amyloid-beta	5	14	35.7142857142857	0.0364432792412256	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CYP1A1; CYP2E1; ADH1A; CYP2C9; UGT1A1; CYP2C19; UGT1A7;	GO:0017144~drug metabolic process	7	25	28	0.0374342131271943	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	MID1; GLI2; HOXB1; BMP5; SHH; GRHL3; FOXJ1; TBX5;	GO:0007389~pattern specification process	8	31	25.8064516129032	0.0383791101000285	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CA2; ASS1; KRT14; S100A8; APOBEC1; HAAO; GGH; SLC30A2;	GO:0010043~response to zinc ion	8	31	25.8064516129032	0.0383791101000285	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	GPR31; CXCL2; IL10; TLR9;	GO:0002237~response to molecule of bacterial origin	4	8	50	0.0387561241430106	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	PPP1CA; PPP1R3F; PPP1R3B; INPP5K;	GO:0005979~regulation of glycogen biosynthetic process	4	8	50	0.0387561241430106	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	ERN1; MARK3; MAP2K2; PINK1;	GO:0036289~peptidyl-serine autophosphorylation	4	8	50	0.0387561241430106	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	ANG; MOGAT2; MOGAT1;	GO:0006651~diacylglycerol biosynthetic process	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	SLC22A2; ATP8B1; SLC22A3;	GO:0006855~drug transmembrane transport	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CHP2; BMP2; RGN;	GO:0010922~positive regulation of phosphatase activity	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	IDO1; TDO2; IDO2;	GO:0019441~tryptophan catabolic process to kynurenine	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	LTF; RARRES2; IL36RN;	GO:0019732~antifungal humoral response	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	EDN1; EDN3; CPE;	GO:0030072~peptide hormone secretion	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	BMP4; IHH; FOXJ1;	GO:0033085~negative regulation of T cell differentiation in thymus	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	APOA1; APOE; APOBEC1;	GO:0042158~lipoprotein biosynthetic process	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CHRM1; P2RY1; P2RY12;	GO:0043270~positive regulation of ion transport	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	APOC1; APOC3; CCDC3;	GO:0045833~negative regulation of lipid metabolic process	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	STATH; CHRM1; AQP5;	GO:0046541~saliva secretion	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	DRD2; DRD1; GDNF;	GO:0051584~regulation of dopamine uptake involved in synaptic transmission	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	EDNRB; P2RY1; VIP;	GO:0060406~positive regulation of penile erection	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	POMC; GCGR; PHLDA2;	GO:0070873~regulation of glycogen metabolic process	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	GJB5; GJB1; GJB2;	GO:1905867~epididymis development	3	5	60	0.0390257851208109	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	AKAP3; GLRA1; SYT8; PLCD4; ROPN1B; TNP2;	GO:0007340~acrosome reaction	6	17	35.2941176470588	0.0391787085743018	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	F8; F2; F9; F11; GP1BA; GP5;	GO:0007597~blood coagulation, intrinsic pathway	6	17	35.2941176470588	0.0391787085743018	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	ODAM; CLDN5; CLDN3; RAMP3; ALOX12B; AGR2; CRP; IGF1; REG1A; CDK1; KIT; BMP2; BMP4; BMP7; DRD1; ERBB3; ITGB8; CALCR; HOXD3; CDH5; IL13; ID1; CASR; PTGFR; GCGR; ACTC1; LCN2; ID3; SRY; CNTN1; PKP1; ANGPT1; NR0B2; SMAD1; NTRK2; OCLN; ZC3H12A; SLC26A9; IQGAP3; CLDN19; VSTM2A; TESC; SEC16B; OVOL2; GATA5; C1QTNF1; MYLK2; EPB41L4B; TREM2; PPARGC1A; LAMP3; IL1F10; IL37; IL36G; IL36B;	GO:0010628~positive regulation of gene expression	55	374	14.7058823529412	0.03935047315798	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	PLAU; RNASE2; CCL2; CXCL2; CXCR2; L1CAM; CCR6; NCKAP1L; CCL8; CCL7; MAP2K1; CMTM8; MOSPD2; CMTM7; PROK2; ZNF580; CYSLTR1; CXCR3; CCR10; CXCR5; CCR7; XCR1; CCR2; CCR5;	GO:0006935~chemotaxis	24	122	19.672131147541	0.0401063420423962	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	AKR1B15; PIR; PRODH; HR; AKR1B10; FMO6P; ALOX12B; CYP7B1; BBOX1; CH25H; CYP1A1; CYP2E1; LIPF; GSTA1; SOD3; CYP2C9; BMP2; CYP11B1; TYRP1; VCAM1; AOC1; HSD11B1; RRM2; FMO3; UQCRC1; CYP2C19; NOS2; HSD17B2; AKR1C3; ALDH1A3; TDO2; CYP4F8; CYP4A11; SELENBP1; PTGIS; CYP4A22; TXNDC8; CYB5R2; HEPHL1; IYD; IDO2; FA2H; SCD5; CYP4Z1; P3H2; RDH10; CYP4X1; CYP4Z2P; SDR16C5; CHDH; SDR9C7; HGD; COX4I2; RDH12; IL4I1; ALOXE3; EGLN3; SRD5A3; BCO1; CYP4F11; VAT1L; NOX4; DUOX2; DUOX1; STAB1; CYP39A1; RDH8; STEAP1; CYB5R1; HIGD1A; CYP2F1; CYP2C18; CYP2S1; PTGES;	GO:0055114~oxidation-reduction process	74	526	14.0684410646388	0.0420827865057911	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	RGS10; OXT; TH; DBH; CNR2; DRD3; RGS2; ASIC1; RGS17;	GO:0001975~response to amphetamine	9	33	27.2727272727273	0.0430722823753908	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	TERT; ERN1; GNAI2; NQO2; IL10; FGF9; LDLRAP1; MAP3K5; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	9	33	27.2727272727273	0.0430722823753908	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	CLDN3; CLDN1; CDH5; OCLN; GRHL2; MARVELD2; POF1B; MARVELD3; CRB3;	GO:0070830~bicellular tight junction assembly	9	38	23.6842105263158	0.0432205158789799	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	PLA2G10; PLA2G5; PLA2G4E; PLA2G4F; PLA2G2F; PLA2G3; PLA2G2D;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	7	26	26.9230769230769	0.0435153554330562	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	GLP2R; ASS1; GJB2; PCK1; GCGR; ADCY2; FGF21;	GO:0071377~cellular response to glucagon stimulus	7	26	26.9230769230769	0.0435153554330562	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	ASS1; CXCL10; CTSG; TFPI; MRC1; EDNRB; IL12B; NOS2; CXCL6; LCN2; CEBPE; ZC3H12A; TNIP3; PLSCR4; PPARGC1A; CXCL1; NR1H4; IL36B; CXCL13; IL1F10; CXCL11; IL36RN; CXCL9; DEFA5; DEFA6; IL36G; IL37;	GO:0071222~cellular response to lipopolysaccharide	27	163	16.5644171779141	0.0436875529285911	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	NPHS1; KCNK5; SCNN1G; CLCNKB; AMN; UGT1A7; ATP6V0A4; CLDN16;	GO:0007588~excretion	8	32	25	0.0438808635519632	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CXCL13; KRT1; EFNA1; ID1; EMP2; GPNMB; SFRP1; PROK1;	GO:0045765~regulation of angiogenesis	8	32	25	0.0438808635519632	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	ADCYAP1; ADCYAP1R1; SCTR; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	5	15	33.3333333333333	0.0446738889793886	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	PHOX2A; GFRA3; NTRK1; GDNF; TFAP2B;	GO:0048485~sympathetic nervous system development	5	15	33.3333333333333	0.0446738889793886	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	PGR; TACSTD2; EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.0446738889793886	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	BMP4; FOXA1; FOXF1; HHIP; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	5	15	33.3333333333333	0.0446738889793886	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	ID1; CASR; KLF5; ANO1; KLF15;	GO:1901653~cellular response to peptide	5	15	33.3333333333333	0.0446738889793886	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	RAG1; NCKAP1L; SPNS2; P2RX7; GPR174; SLC46A2; SIT1; PPP2R3C;	GO:0043029~T cell homeostasis	8	28	28.5714285714286	0.0453335133324385	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
down	CXCR2; LTK; BNIP3; MAP3K5; TIGAR;	GO:0010666~positive regulation of cardiac muscle cell apoptotic process	5	13	38.4615384615385	0.045427546241626	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	TCF21; TDGF1; FOXF1; COL13A1;	GO:0001763~morphogenesis of a branching structure	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	APOA1; APOE; APOC3; APOA4;	GO:0034378~chylomicron assembly	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	HOXD10; GDF5; TFAP2B; TBX5;	GO:0035136~forelimb morphogenesis	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	BMP5; TCF15; RDH10; STRA6;	GO:0043583~ear development	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	IGFBP3; IGFBP4; IGFBP5; NKX6-1;	GO:0044342~type B pancreatic cell proliferation	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	ATP8B1; GABRA5; GABRB2; USH1C;	GO:0060119~inner ear receptor cell development	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	PATE4; SLURP1; LYPD6; LYPD6B;	GO:0099601~regulation of neurotransmitter receptor activity	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	HRG; DCN; IL12B; XDH;	GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CX3CL1; ZC3H12A; NR1H4; IL37;	GO:1904468~negative regulation of tumor necrosis factor secretion	4	10	40	0.0454459324569377	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	BMP7; HOXD10; GJA5; GDF5; PRRX1; DLX5; SHH; TBX5; TBX4;	GO:0030326~embryonic limb morphogenesis	9	39	23.0769230769231	0.0486112066221068	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CYP2F1; CYP2C19; CYP2E1; CYP2S1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	6	21	28.5714285714286	0.0488810062596521	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
up	CLDN1; CLDN6; CXADR; OCLN; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	6	21	28.5714285714286	0.0488810062596521	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
down	IFNB1; MS4A1; IL10; CD40LG; CD70; PRKCD; IFNA21; IFNW1; IFNA5;	GO:0042100~B cell proliferation	9	34	26.4705882352941	0.0491934762616975	0.907385417999047	1	1	0.999982718763684	0.999982718763684	1
up	APOE; APOC1; APOC3; CYP2E1; LIPF; APOBEC1; PNLIPRP2; NKX2-3;	GO:0006641~triglyceride metabolic process	8	33	24.2424242424242	0.0498768679913386	0.649525096392247	1	1	0.999999999904809	0.999999999904809	1
